Pfizer Inc., founded in 1849 and headquartered in New York City, is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and vaccines. Pfizer's notable products include vaccines such as Comirnaty for COVID-19 and treatments like Lyrica and Ibrance, making it a key player in the healthcare industry.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Pfizer began issuing bonds as part of its capital structure in the early 1990s, with significant issuances occurring to finance acquisitions and research initiatives. Notably, in 2020, Pfizer issued $1.25 billion in green bonds to support environmentally sustainable projects, a move that garnered attention in the financial markets. Current yields on Pfizer's bonds are competitive within the pharmaceutical sector, reflecting the company's stable credit profile and solid revenue generation from its diverse portfolio.